Differential effects of interleukin-1β and S100B on amyloid precursor protein in rat retinal neurons

Clinical Ophthalmology

Volumn 3, Issue 1, 2009, Pages 235-242

  Anderson, Peter J B ^a   Watts, Helena R ^a   Jen, Sheila ^a   Gentleman, Stephen M ^a   Moncaster, Juliet A ^a   Walsh, D T ^a   Jen, Ling Sun ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Amyloid ; Interleukin 1 ; Retina; S100B

Indexed keywords

AMYLOID PRECURSOR PROTEIN; INTERLEUKIN 1BETA; PROTEIN S100B;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GLIA CELL; IMMUNOREACTIVITY; MUELLER CELL; NERVE CELL; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; RETINA; RETINA NERVE CELL; WESTERN BLOTTING;

EID: 77953413288     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/opth.s2684     Document Type: Article

References (34)

1. Akaaboune M, Allinquant B, Farza H, et al. 2000. Developmental regulation of amyloid precursor protein at the neuromuscular junction in mouse skeletal muscle. Mol Cell Neurosci, 15:355-67.
2. Bamforth SD, Lightman SL, Greenwood J. 1997. Interleukin-1 beta-induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine. Am J Pathol, 150:329-40.
3. Bhattacharyya A, Oppenheim RW, Prevette D, et al. 1992. S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in vivo. J Neurobiol, 23:451-66.
4. Bresciani LG, Walsh DT, Gentleman SM, et al. 2002. Developmental regulation and possible alternative cleavage of presenilin 1 in the rat retina. Mol Cell Neurosci, 21:239-49.
5. Buxbaum JD, Oishi M, Chen HI, et al. 1992. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc Natl Acad Sci USA, 89:10075-8.
6. Chen ST, Gentleman SM, Garey LJ, et al. 1996. Distribution of beta-amyloid precursor and B-cell lymphoma protooncogene proteins in the rat retina after optic nerve transection or vascular lesion. J Neuropathol Exp Neurol, 55:1073-82.
7. Chen ST, Jen A, Gentleman SM, et al. 1999. Effects of bFGF and TGFbeta on the expression of amyloid precursor and B-cell lymphoma protooncogene proteins in the rat retina. Neuroreport, 10:509-12.
8. Ciallella JR, Ikonomovic MD, Paljug WR, et al. 2002. Changes in expression of amyloid precursor protein and interleukin-1beta after experimental traumatic brain injury in rats. J Neurotrauma, 19:1555-67.
9. Croucher MJ, Patel H, Walsh DT, et al. 2003. Up-regulation of soluble amyloid precursor protein fragment secretion in the rat retina in vivo by metabotropic glutamate receptor stimulation. Neuroreport, 14:2271-4.
10. Dash PK, Moore AN. 1995. Enhanced processing of APP induced by IL-1 beta can be reduced by indomethacin and nordihydroguaiaretic acid. Biochem Biophys Res Commun, 208:542-8.
11. Donato R. 2001. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol, 33:637-68.
12. Gitter BD, Boggs LN, May PC, et al. 2000. Regulation of cytokine secretion and amyloid precursor protein processing by proinflammatory amyloid beta (A beta). Ann N Y Acad Sci, 917:154-64.
13. Goldgaber D, Harris HW, Hla T, et al. 1989. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci USA, 86:7606-10.
14. Griffin WS, Sheng JG, Roberts GW, et al. 1995. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol, 54:276-81.
15. Griffin WS, Sheng JG, Royston MC, et al. 1998. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression. Brain Pathol, 8:65-72.
16. Guo QX, Chau RM, Yang SZ, et al. 1991. Development of choline acetyltransferase-immunoreactive neurons in normal and intracranially transplanted retinas in rats. Brain Res Dev Brain Res, 62:177-87.
17. Guo QX, Yu MC, Garey LJ, et al. 1992a. Development of parvalbumin immunoreactive neurons in normal and intracranially transplanted retinas in the rat. Exp Brain Res, 90:359-68.
18. Guo QX, Yang SZ, Liang CL, et al. 1992b. Tyrosine-hydroxylase- immunoreactive neurons in retinal transplants in the rat. Biol Signals, 1:46-56.
19. Hardy J. 1997. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci, 20:154-9.
20. Jen LS, Hart AJ, Jen A, et al. 1998. Alzheimer's peptide kills cells of retina in vivo. Nature, 392:140-1.
21. Kim SH, Smith CJ, Van Eldik LJ. 2004. Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1[beta] production. Neurobiol Aging, 25:431-9.
22. Kligman D, Marshak DR. 1985. Purification and characterization of a neurite extension factor from bovine brain. Proc Natl Acad Sci USA, 82:7136-9.
23. Li Y, Wang J, Sheng JG, et al. 1998. S100 beta increases levels of beta-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J Neurochem, 71:1421-8.
24. Morin PJ, Abraham CR, Amaratunga A, et al. 1993. Amyloid precursor protein is synthesized by retinal ganglion cells, rapidly transported to the optic nerve plasma membrane and nerve terminals, and metabolized. J Neurochem, 61:464-73.
25. Mrak RE, Sheng JG, Griffin WS. 1996. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J Neuropathol Exp Neurol, 55:273-9.
26. Mrak RE, Griffin WS. 2001. The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease. Neurobiol Aging, 22:915-C22.
27. Sastre M, Dewachter I, Landreth GE, et al. 2003. Nonsteroidal antiinfl ammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase. J Neurosci, 23:9796-804.
28. Sheng JG, Mrak RE, Rovnaghi CR, et al. 1996. Human brain S100 beta and S100 beta mRNA expression increases with age: pathogenic implications for Alzheimer's disease. Neurobiol Aging, 17:359-63.
29. Sheng JG, Mrak RE, Bales KR, et al. 2000. Overexpression of the neuritotrophic cytokine S100beta precedes the appearance of neuritic beta-amyloid plaques in APPV717F mice. J Neurochem, 74:295-301.
30. Walsh DT, Bresciani L, Saunders D, et al. 2005. Amyloid beta peptide causes chronic glial cell activation and neuro-degeneration after intravitreal injection. Neuropathol Appl Neurobiol, 31:491-502.
31. Walsh DT, Montero RM, Bresciani LG, et al. 2002. Amyloid-beta peptide is toxic to neurons in vivo via indirect mechanisms. Neurobiol Dis, 10:20-7.
32. Watts HR, Vince V, Walsh DT, et al. 2007. Alterations in presenilin 1 processing by amyloid-beta peptide in the rat retina. Exp Brain Res, 181:69-77.
33. Winningham-Major F, Staecker JL, Barger SW, et al. 1989. Neurite extension and neuronal survival activities of recombinant S100 beta proteins that differ in the content and position of cysteine residues. J Cell Biol, 109: 3063-71.
34. Yang SZ, Guo QX, Tsang D, et al. 1992. Development of gamma-aminobutyric acid-immunoreactive neurons in normal and intracranially transplanted retinas in rats. Brain Res Bull, 28:543-50.